837 related articles for article (PubMed ID: 9596999)
21. Antiproliferative function of p27kip1 is frequently inhibited in highly malignant Burkitt's lymphoma cells.
Barnouin K; Fredersdorf S; Eddaoudi A; Mittnacht S; Pan LX; Du MQ; Lu X
Oncogene; 1999 Nov; 18(46):6388-97. PubMed ID: 10597239
[TBL] [Abstract][Full Text] [Related]
22. Stem cell factor inhibits erythroid differentiation by modulating the activity of G1-cyclin-dependent kinase complexes: a role for p27 in erythroid differentiation coupled G1 arrest.
Tamir A; Petrocelli T; Stetler K; Chu W; Howard J; Croix BS; Slingerland J; Ben-David Y
Cell Growth Differ; 2000 May; 11(5):269-77. PubMed ID: 10845428
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
Liang YC; Lin-Shiau SY; Chen CF; Lin JK
J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699
[TBL] [Abstract][Full Text] [Related]
24. Loss of p27Kip1 from cyclin E/cyclin-dependent kinase (CDK) 2 but not from cyclin D1/CDK4 complexes in cells transformed by polyamine biosynthetic enzymes.
Ravanko K; Järvinen K; Paasinen-Sohns A; Hölttä E
Cancer Res; 2000 Sep; 60(18):5244-53. PubMed ID: 11016654
[TBL] [Abstract][Full Text] [Related]
25. Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cells.
Neve RM; Sutterlüty H; Pullen N; Lane HA; Daly JM; Krek W; Hynes NE
Oncogene; 2000 Mar; 19(13):1647-56. PubMed ID: 10763821
[TBL] [Abstract][Full Text] [Related]
26. Antitumor activity of UCN-01 in carcinomas of the head and neck is associated with altered expression of cyclin D3 and p27(KIP1).
Patel V; Lahusen T; Leethanakul C; Igishi T; Kremer M; Quintanilla-Martinez L; Ensley JF; Sausville EA; Gutkind JS; Senderowicz AM
Clin Cancer Res; 2002 Nov; 8(11):3549-60. PubMed ID: 12429646
[TBL] [Abstract][Full Text] [Related]
27. Cyclin-dependent kinase (cdk) inhibitors/cdk4/cdk2 complexes in early stages of mouse mammary preneoplasia.
Said TK; Moraes RC; Singh U; Kittrell FS; Medina D
Cell Growth Differ; 2001 Jun; 12(6):285-95. PubMed ID: 11432803
[TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor beta-induced activation of cyclin E-cdk2 kinase and down-regulation of p27Kip1 in C3H 10T1/2 mouse fibroblasts.
Ravitz MJ; Yan S; Herr KD; Wenner CE
Cancer Res; 1995 Apr; 55(7):1413-6. PubMed ID: 7882344
[TBL] [Abstract][Full Text] [Related]
29. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
Greider C; Chattopadhyay A; Parkhurst C; Yang E
Oncogene; 2002 Nov; 21(51):7765-75. PubMed ID: 12420213
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of transforming growth factor on cell cycle regulatory molecules in human myeloid leukemia cells.
Hu X; Zhang X; Zhong Q; Fisher AB; Bryington M; Zuckerman KS
Oncogene; 2001 Oct; 20(47):6840-50. PubMed ID: 11687963
[TBL] [Abstract][Full Text] [Related]
31. Differences in the mechanisms of growth control in contact-inhibited and serum-deprived human fibroblasts.
Dietrich C; Wallenfang K; Oesch F; Wieser R
Oncogene; 1997 Nov; 15(22):2743-7. PubMed ID: 9401001
[TBL] [Abstract][Full Text] [Related]
32. Early G1 growth arrest of hybridoma B cells by DMSO involves cyclin D2 inhibition and p21[CIP1] induction.
Ponzio G; Loubat A; Rochet N; Turchi L; Rezzonico R; Farahi Far D; Dulic V; Rossi B
Oncogene; 1998 Sep; 17(9):1159-66. PubMed ID: 9764826
[TBL] [Abstract][Full Text] [Related]
33. Changes in E2F binding after phenylbutyrate-induced differentiation of Caco-2 colon cancer cells.
Wang QM; Feinman R; Kashanchi F; Houghton JM; Studzinski GP; Harrison LE
Clin Cancer Res; 2000 Jul; 6(7):2951-8. PubMed ID: 10914745
[TBL] [Abstract][Full Text] [Related]
34. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F.
Leone G; DeGregori J; Sears R; Jakoi L; Nevins JR
Nature; 1997 May; 387(6631):422-6. PubMed ID: 9163430
[TBL] [Abstract][Full Text] [Related]
35. Retinoblastoma protein-overexpressing HL60 cells resistant to 1,25-dihydroxyvitamin D3 display increased CDK2 and CDK6 activity and shortened G1 phase.
Wang QM; Luo X; Kheir A; Coffman FD; Studzinski GP
Oncogene; 1998 May; 16(21):2729-37. PubMed ID: 9652739
[TBL] [Abstract][Full Text] [Related]
36. A vitamin D3 analog induces a G1-phase arrest in CaCo-2 cells by inhibiting cdk2 and cdk6: roles of cyclin E, p21Waf1, and p27Kip1.
Scaglione-Sewell BA; Bissonnette M; Skarosi S; Abraham C; Brasitus TA
Endocrinology; 2000 Nov; 141(11):3931-9. PubMed ID: 11089522
[TBL] [Abstract][Full Text] [Related]
37. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
Orend G; Hunter T; Ruoslahti E
Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134
[TBL] [Abstract][Full Text] [Related]
38. Complex regulation of CDKs and G1 arrest during the granulocytic differentiation of human myeloblastic leukemia ML-1 cells.
Shimizu T; Awai N; Takeda K
Oncogene; 2000 Sep; 19(40):4640-6. PubMed ID: 11030153
[TBL] [Abstract][Full Text] [Related]
39. Evidence for a p23 caspase-cleaved form of p27[KIP1] involved in G1 growth arrest.
Loubat A; Rochet N; Turchi L; Rezzonico R; Far DF; Auberger P; Rossi B; Ponzio G
Oncogene; 1999 Jun; 18(22):3324-33. PubMed ID: 10362353
[TBL] [Abstract][Full Text] [Related]
40. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]